In COVID-19, EV-TF activity was positively correlated with D-dimer, prothrombin time, and von Willebrand factor levels, indicating a link between TF-positive EVs, coagulation, and endothelial activation, which may contribute to thrombosis in COVID-19 patients (128). This evidence concerns the gene VWF and COVID-19.